LimmaTech Biologics Company
LimmaTech Biologics is a clinical-stage biotech company that develops vaccines to prevent life-threatening diseases. The company uses proprietary self-adjuvanting and multi-antigen vaccine platforms to address microbial infections that are becoming resistant to treatments. Its research and development efforts aim to create vaccines tailored to specific pathogens. LimmaTech Biologics works on expanding its pipeline to provide solutions for infectious diseases with limited treatment options.
Connections
Employee Number:
101-250
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Vaccines & Immunotherapy
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 44 733 8585
Investors:
AXA Investment Managers, Adjuvant Capital, CARB-X, Repair Impact Fund, Tenmile
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland
Founders:
Michael Kowarik, Paul Wolfrom, Veronica Gambillara Fonck